Delivery Order SPE2DR25D3303-SPE2DR26F63M3
Award Date 12/11/25
Potential Completion Date 12/12/25
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,558.42 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of RINVOQ ER 15mg tablets (30-count supply). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for RINVOQ ER 15 mg tablets in a quantity of 30 units, with a ceiling value of $17,417.68. This firm fixed-price delivery order, which has no set-aside designation, is set to be completed by December 9, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a pharmaceutical product used in the treatment of inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) valued at $12,222.99. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation, indicating the contract was competed openly among...
- The Defense Logistics Agency awarded a $14,967.08 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for RINVOQ ER 45 mg tablets (28-count units). This is a firm fixed-price, non-set-aside contract with a completion date of December 12, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value transaction within AmerisourceBergen's extensive portfolio of pharmaceutical supply contracts supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $8,372.73 to AmerisourceBergen Drug Corp on August 19, 2025, for RINVOQ ER 15 mg tablets (30-count units). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating the contractor's ability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $87,963.69 and an ultimate completion date of December 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $70,077.70 on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply role within the federal healthcare procurement system. The products will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed price contract valued at $11,902.23. This is a non-set-aside competitive award with an ultimate completion date of December 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,840.95 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 24, 2025, with completion targeted for November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,191.05 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The contract is not set aside and will be performed at the vendor's corporate office location in...